Perrigo Hopes Esomeprazole Helps Make Private Label OTCs A Bright Spot
Executive Summary
The firm lowers its 2016 guidance as its European branded OTC drug and nutritional product business and its Rx topicals business appear to be major obstacles to escaping its earnings slump.
You may also be interested in...
Perrigo's Rx Business Looks Ready To Sell, Says Hedge Fund Investor
Starboard Value states says Perrigo "severely mismanaged" its entry into branded consumer health through the acquisition of a German firm and showed "misguided confidence" in encouraging shareholders to reject Mylan's tender.
Perrigo Plays To OTC Strength With GoodSense Firm Acquisition
Geiss, Destin & Dunn's GoodSense brand includes more than 1,500 OTC drugs and nutritional products. The deal could help diminish the impact of earnings headwinds on Perrigo's branded consumer health and Rx generic topicals businesses.
Perrigo Plays To OTC Strength With GoodSense Firm Acquisition
Geiss, Destin & Dunn's GoodSense brand includes more than 1,500 OTC drugs and nutritional products. The deal could help diminish the impact of earnings headwinds on Perrigo's branded consumer health and Rx generic topicals businesses.